Exploring the viability of Zeatin as a prospective therapeutic candidate for investigating the complex interplay between severe acute respiratory syndrome coronavirus (SARS-CoV) and Alzheimer’s disease

被引:0
|
作者
A. S. Sriranjini
Ashish Thapliyal
Kumud Pant
机构
[1] Graphic Era Deemed to be University,Department of Biotechnology
关键词
SARS-CoV; COVID; Alzheimer’s; Pharmacology; APOE4; ACE2; SPIKE;
D O I
10.1007/s40203-024-00195-3
中图分类号
学科分类号
摘要
The present research aims to explore the intricate link between SARS-CoV infection and susceptibility to Alzheimer’s disease, focusing on the role of APOE4, a genetic factor associated with both conditions. Our research aims to uncover shared molecular pathways, considering APOE4’s impact on lipid metabolism, immune responses, and neuroinflammation relevant to COVID-19 and AD. The Chyawanprash phytocompounds were subjected to in-silico ADMET profiling and Zeatin a neuroprotective cytokinin emerged as a promising regulator of the ACE2-SPIKE complex as it exhibits favourable pharmacological attributes, presenting as a non-substrate for Permeability glycoprotein, low Protein Binding Percentage, and distinctive toxicity endpoints. Therapeutic candidate. Zeatin’s robust binding disrupts the intricate APOE4-ACE2-SPIKE interplay (AAS), offering a potential therapeutic avenue that is further corroborated by Molecular dynamic simulation as the system remained stable without any major fluctuation throughout the 100ns simulation. The AAS binding free energy, determined as -124.849 +/- 15.513 KJ/mol using MMPBSA assay, reveals significant contributions to complex stability from amino acids including, GLN41: 1.211 kcal/mol, GLU340: 1.188 kcal/mol, ALA344: 1.198 kcal/mol, while ARG38: 2.011 kcal/mol establishes pivotal strong bonds integral to the interaction between AAS and Zeatin. Rigorous cytotoxicity assessments reveal Zeatin’s safety profile, highlighting its inhibitory effect on LN18 cell viability that sharply decreases to 32.47% at 200 µg/ml, underscoring its modulatory impact on cellular metabolism. These findings enhance our understanding of the convergent mechanisms linking SARS-CoV and AD, providing valuable insights for potential therapeutic interventions. Further research is warranted to elucidate the specific pathways and molecular mechanisms through which zeatin exerts its protective effects.
引用
收藏
相关论文
共 50 条
  • [41] The YXXempty set motif within the severe acute respiratory syndrome coronavirus (SARS-CoV) 3a protein is crucial for its intracellular transport
    Minakshi, Rinki
    Padhan, Kartika
    VIROLOGY JOURNAL, 2014, 11
  • [42] A Rare Case of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Induced Hartnup Disease
    Tanchez, Christopher
    Taunk, Pardeep
    Sinha, Neera
    Trillo, John W.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S1073 - S1073
  • [43] Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Associated Urogenital Disease: A Current Update
    Chu, Guangdi
    Jiao, Wei
    Xie, Fei
    Zhang, Mingxin
    Niu, Haitao
    WORLD JOURNAL OF MENS HEALTH, 2021, 39 (03): : 444 - 453
  • [44] The relationship between severe acute respiratory syndrome coronavirus 2 (SARS - COV-2) pandemic and fragmented QRS
    Bektas, Osman
    Cerik, Idris Bugra
    Cerik, Hatun Ozturk
    Karagoz, Ahmet
    Kaya, Yasemin
    Dereli, Seckin
    Kaya, Ahmet
    Dogan, Ahmet
    JOURNAL OF ELECTROCARDIOLOGY, 2020, 62 : 10 - 13
  • [45] Glycopeptide Antibiotics Potently Inhibit Cathepsin L in the Late Endosome/Lysosome and Block the Entry of Ebola Virus, Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)
    Zhou, Nan
    Pan, Ting
    Zhang, Junsong
    Li, Qianwen
    Zhang, Xue
    Bai, Chuan
    Huang, Feng
    Peng, Tao
    Zhang, Jianhua
    Liu, Chao
    Tao, Liang
    Zhang, Hui
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2016, 291 (17) : 9218 - 9232
  • [46] Two-way antigenic cross-reactivity between severe acute respiratory syndrome coronavirus (SARS-CoV) and group 1 animal CoVs is mediated through an antigenic site in the n-terminal region of the SARS-CoV nucleoprotein
    Vlasova, Anastasia N.
    Zhang, Xinsheng
    Hasoksuz, Mustafa
    Nagesha, Hadya S.
    Haynes, Lia M.
    Fang, Ying
    Lu, Shan
    Saif, Linda J.
    JOURNAL OF VIROLOGY, 2007, 81 (24) : 13365 - 13377
  • [47] Relationship Between Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and the Etiology of Acute Kidney Injury (AKI)
    Chong, Woon H.
    Saha, Biplab K.
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2021, 361 (03): : 287 - 296
  • [48] The human severe acute respiratory syndrome coronavirus (SARS-CoV) 8b protein is distinct from its counterpart in animal SARS-CoV and down-regulates the expression of the envelope protein in infected cells
    Keng, Choong-Tat
    Choi, Yook-Wah
    Welkers, Matthijs R. A.
    Chan, Daphne Z. L.
    Shen, Shuo
    Lim, Seng Gee
    Hong, Wanjin
    Tan, Yee-Joo
    VIROLOGY, 2006, 354 (01) : 132 - 142
  • [49] Epidemiology of Coronavirus Disease 2019 (COVID-19) Caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
    Wei, Maoti
    Yang, Ning
    Wang, Fenghua
    Zhao, Guoping
    Gao, Hongwei
    Li, Yuming
    DISASTER MEDICINE AND PUBLIC HEALTH PREPAREDNESS, 2020, 14 (06) : 796 - 804
  • [50] Induction of protective immunity against severe acute respiratory syndrome coronavirus (SARS-CoV) infection using highly attenuated recombinant vaccinia virus DIs
    Ishii, Koji
    Hasegawa, Hideki
    Nagata, Noriyo
    Mizutani, Tetsuya
    Morikawa, Shigeru
    Suzuki, Tetsuro
    Taguchi, Fumihiro
    Tashiro, Masato
    Takemori, Toshitada
    Miyamura, Tatsuo
    Tsunetsugu-Yokota, Yasuko
    VIROLOGY, 2006, 351 (02) : 368 - 380